CLINICAL_TRIALS
trial_result
· 2017-10-16
Clinical Trial Update: Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma [Phase 1, Phase 2]
Summary
This study updates Phase 1/2 trial results for reduced-intensity conditioning followed by donor peripheral blood stem cell transplantation in patients with mult…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Fred Hutchinson Cancer Center | Conditions: Refractory Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-10-16